Defunct Company
Total Trials
9
As Lead Sponsor
3
As Collaborator
6
Total Enrollment
618
NCT00939237
Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease
Phase: Phase 3
Role: Collaborator
Start: Jul 31, 2009
Completion: May 31, 2011
NCT01199549
Bioavailability Study of Different Dietary Antioxidants in Volunteers
Phase: N/A
Role: Lead Sponsor
Start: Sep 30, 2009
Completion: Sep 30, 2010
NCT01100385
TomVasc - Vascular Effects of Tomato Extract
Start: Feb 28, 2010
Completion: May 31, 2012
NCT00905931
Lycopene Following Aneurysmal Subarachnoid Haemorrhage
Phase: Phase 2
Start: Sep 30, 2010
Completion: Oct 31, 2012
NCT04637269
Anti-BCMA CAR-T Cell Therapy for the R/R Multiple Myeloma
Phase: Early Phase 1
Start: Nov 17, 2020
Completion: Nov 1, 2023
NCT04803929
Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)
Start: Mar 3, 2021
Completion: Mar 1, 2026
NCT04706936
Novel BCMA-targeted CAR-T Cell Therapy for Multiple Myeloma
Phase: Phase 1
Start: Apr 1, 2021
Completion: Apr 30, 2024
NCT06461624
Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular Carcinoma
Start: Jul 1, 2024
Completion: Oct 31, 2027
NCT06705725
Phase I Clinical Study of CBG002 CAR-T Cell in Treatment of Relapsed/refractory Multiple Myeloma
Start: Dec 26, 2024
Completion: Feb 22, 2028